Dopamine partial agonists: a new class of antipsychotic (Q35688765)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2004

edit

Language	Label	Description	Also known as
English	Dopamine partial agonists: a new class of antipsychotic	scientific article published on January 2004

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15015905

retrieved

9 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Dopamine partial agonists: a new class of antipsychotic (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15015905

retrieved

9 August 2017

author

Jeffrey Lieberman

series ordinal

1

object named as

Jeffrey A Lieberman

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15015905

retrieved

9 August 2017

publication date

1 January 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15015905

retrieved

9 August 2017

published in

CNS Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15015905

retrieved

9 August 2017

volume

18

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15015905

retrieved

9 August 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15015905

retrieved

9 August 2017

page(s)

251-267

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15015905

retrieved

9 August 2017

cites work

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imaging dopamine transmission in schizophrenia. A review and meta-analysis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonergic basis of antipsychotic drug effects in schizophrenia.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bringing order to the glutamate chaos in schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine in schizophrenia: a review and reconceptualization

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine agonists in schizophrenia: a review

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotics: mechanism of action.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The dopamine hypothesis of schizophrenia: current status, future prospects.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An integrated view of pathophysiological models of schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine D4 receptors elevated in schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controls

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial dopamine agonists in the treatment of psychosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The neuropathology of schizophrenia. A critical review of the data and their interpretation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroleptic-induced hyperprolactinemia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology, morbidity, and treatment of overweight and obesity.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strategy for modulation of central dopamine transmission based on the partial agonist concept in schizophrenia therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine attenuates meta-chlorophenylpiperazine (mCPP)-induced plasma cortisol increases in schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine receptors: from structure to function

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of negative symptoms in schizophrenia with amisulpride

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine receptors and transporters in Parkinson's disease and schizophrenia.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do classical hallucinogens act as 5-HT2 agonists or antagonists?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of serotonin in antipsychotic drug action

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15015905

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00023210-200418040-00005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15015905

retrieved

9 August 2017

Dimensions Publication ID

1014575185

0 references

PubMed publication ID

15015905

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15015905

retrieved

9 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35688765&oldid=2197627185"